nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—brain cancer—Triamcinolone—multiple sclerosis	0.0733	0.445	CpDpCtD
Methylprednisolone—Corticosteroid Hormone Receptor Agonists—Betamethasone—multiple sclerosis	0.0632	0.209	CiPCiCtD
Methylprednisolone—Corticosteroid Hormone Receptor Agonists—Dexamethasone—multiple sclerosis	0.0632	0.209	CiPCiCtD
Methylprednisolone—Corticosteroid Hormone Receptor Agonists—Triamcinolone—multiple sclerosis	0.061	0.202	CiPCiCtD
Methylprednisolone—Corticosteroid Hormone Receptor Agonists—Prednisolone—multiple sclerosis	0.0591	0.196	CiPCiCtD
Methylprednisolone—Corticosteroid Hormone Receptor Agonists—Prednisone—multiple sclerosis	0.0558	0.185	CiPCiCtD
Methylprednisolone—Dexamethasone—multiple sclerosis	0.0456	0.208	CrCtD
Methylprednisolone—Betamethasone—multiple sclerosis	0.0456	0.208	CrCtD
Methylprednisolone—Triamcinolone—multiple sclerosis	0.0445	0.203	CrCtD
Methylprednisolone—Prednisone—multiple sclerosis	0.0423	0.193	CrCtD
Methylprednisolone—Prednisolone—multiple sclerosis	0.0412	0.188	CrCtD
Methylprednisolone—brain cancer—Dexamethasone—multiple sclerosis	0.0398	0.242	CpDpCtD
Methylprednisolone—brain cancer—Betamethasone—multiple sclerosis	0.0398	0.242	CpDpCtD
Methylprednisolone—NR3C1—Triamcinolone—multiple sclerosis	0.0166	0.167	CbGbCtD
Methylprednisolone—NR3C1—Betamethasone—multiple sclerosis	0.0142	0.143	CbGbCtD
Methylprednisolone—NR3C1—Prednisolone—multiple sclerosis	0.014	0.141	CbGbCtD
Methylprednisolone—NR3C1—Prednisone—multiple sclerosis	0.0133	0.133	CbGbCtD
Methylprednisolone—osteoarthritis—Prednisone—multiple sclerosis	0.0117	0.0712	CpDpCtD
Methylprednisolone—NR3C1—Dexamethasone—multiple sclerosis	0.00828	0.0832	CbGbCtD
Methylprednisolone—CYP3A4—Fingolimod—multiple sclerosis	0.00474	0.0476	CbGbCtD
Methylprednisolone—ABCB1—Mitoxantrone—multiple sclerosis	0.00372	0.0374	CbGbCtD
Methylprednisolone—ABCB1—Betamethasone—multiple sclerosis	0.00331	0.0333	CbGbCtD
Methylprednisolone—ABCB1—Prednisolone—multiple sclerosis	0.00327	0.0329	CbGbCtD
Methylprednisolone—ABCB1—Prednisone—multiple sclerosis	0.00309	0.031	CbGbCtD
Methylprednisolone—CYP3A4—Triamcinolone—multiple sclerosis	0.00231	0.0233	CbGbCtD
Methylprednisolone—CYP3A4—Mitoxantrone—multiple sclerosis	0.00223	0.0224	CbGbCtD
Methylprednisolone—Exemestane—Prednisone—multiple sclerosis	0.00221	0.0137	CrCrCtD
Methylprednisolone—Exemestane—Prednisolone—multiple sclerosis	0.00216	0.0134	CrCrCtD
Methylprednisolone—CYP3A4—Betamethasone—multiple sclerosis	0.00199	0.02	CbGbCtD
Methylprednisolone—CYP3A4—Prednisolone—multiple sclerosis	0.00196	0.0197	CbGbCtD
Methylprednisolone—ABCB1—Dexamethasone—multiple sclerosis	0.00193	0.0194	CbGbCtD
Methylprednisolone—CYP3A4—Prednisone—multiple sclerosis	0.00185	0.0186	CbGbCtD
Methylprednisolone—ABCB1—Methotrexate—multiple sclerosis	0.00155	0.0156	CbGbCtD
Methylprednisolone—Ciclesonide—Prednisone—multiple sclerosis	0.00147	0.00909	CrCrCtD
Methylprednisolone—Ciclesonide—Prednisolone—multiple sclerosis	0.00143	0.00887	CrCrCtD
Methylprednisolone—Flurandrenolide—Betamethasone—multiple sclerosis	0.00142	0.00877	CrCrCtD
Methylprednisolone—Flurandrenolide—Dexamethasone—multiple sclerosis	0.00142	0.00877	CrCrCtD
Methylprednisolone—Medrysone—Prednisolone—multiple sclerosis	0.00138	0.00853	CrCrCtD
Methylprednisolone—Flumethasone Pivalate—Dexamethasone—multiple sclerosis	0.00137	0.00847	CrCrCtD
Methylprednisolone—Flumethasone Pivalate—Betamethasone—multiple sclerosis	0.00137	0.00847	CrCrCtD
Methylprednisolone—Flumethasone Pivalate—Triamcinolone—multiple sclerosis	0.00134	0.00828	CrCrCtD
Methylprednisolone—Difluprednate—Betamethasone—multiple sclerosis	0.00133	0.0082	CrCrCtD
Methylprednisolone—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.00133	0.0082	CrCrCtD
Methylprednisolone—Difluprednate—Dexamethasone—multiple sclerosis	0.00133	0.0082	CrCrCtD
Methylprednisolone—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.00133	0.0082	CrCrCtD
Methylprednisolone—Halobetasol Propionate—Betamethasone—multiple sclerosis	0.00133	0.0082	CrCrCtD
Methylprednisolone—Halobetasol Propionate—Dexamethasone—multiple sclerosis	0.00133	0.0082	CrCrCtD
Methylprednisolone—Halobetasol Propionate—Triamcinolone—multiple sclerosis	0.0013	0.00801	CrCrCtD
Methylprednisolone—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.0013	0.00801	CrCrCtD
Methylprednisolone—Difluprednate—Triamcinolone—multiple sclerosis	0.0013	0.00801	CrCrCtD
Methylprednisolone—Flurandrenolide—Prednisolone—multiple sclerosis	0.00128	0.00793	CrCrCtD
Methylprednisolone—Testolactone—Betamethasone—multiple sclerosis	0.00125	0.00771	CrCrCtD
Methylprednisolone—Fluocinonide—Dexamethasone—multiple sclerosis	0.00125	0.00771	CrCrCtD
Methylprednisolone—Fluocinonide—Betamethasone—multiple sclerosis	0.00125	0.00771	CrCrCtD
Methylprednisolone—Clocortolone—Betamethasone—multiple sclerosis	0.00125	0.00771	CrCrCtD
Methylprednisolone—Clocortolone—Dexamethasone—multiple sclerosis	0.00125	0.00771	CrCrCtD
Methylprednisolone—Testolactone—Dexamethasone—multiple sclerosis	0.00125	0.00771	CrCrCtD
Methylprednisolone—Prednicarbate—Betamethasone—multiple sclerosis	0.00125	0.00771	CrCrCtD
Methylprednisolone—Prednicarbate—Dexamethasone—multiple sclerosis	0.00125	0.00771	CrCrCtD
Methylprednisolone—Hydrocortamate—Prednisone—multiple sclerosis	0.00123	0.0076	CrCrCtD
Methylprednisolone—Prednicarbate—Triamcinolone—multiple sclerosis	0.00122	0.00753	CrCrCtD
Methylprednisolone—Testolactone—Triamcinolone—multiple sclerosis	0.00122	0.00753	CrCrCtD
Methylprednisolone—Clocortolone—Triamcinolone—multiple sclerosis	0.00122	0.00753	CrCrCtD
Methylprednisolone—Fluocinonide—Triamcinolone—multiple sclerosis	0.00122	0.00753	CrCrCtD
Methylprednisolone—Fluocortolone—Betamethasone—multiple sclerosis	0.00121	0.00749	CrCrCtD
Methylprednisolone—Fluocortolone—Dexamethasone—multiple sclerosis	0.00121	0.00749	CrCrCtD
Methylprednisolone—Hydrocortamate—Prednisolone—multiple sclerosis	0.0012	0.00742	CrCrCtD
Methylprednisolone—Cortisone acetate—Prednisone—multiple sclerosis	0.00119	0.00737	CrCrCtD
Methylprednisolone—Fluocortolone—Triamcinolone—multiple sclerosis	0.00118	0.00732	CrCrCtD
Methylprednisolone—Alclometasone—Dexamethasone—multiple sclerosis	0.00118	0.00728	CrCrCtD
Methylprednisolone—Fluocinolone Acetonide—Betamethasone—multiple sclerosis	0.00118	0.00728	CrCrCtD
Methylprednisolone—Fluocinolone Acetonide—Dexamethasone—multiple sclerosis	0.00118	0.00728	CrCrCtD
Methylprednisolone—Alclometasone—Betamethasone—multiple sclerosis	0.00118	0.00728	CrCrCtD
Methylprednisolone—Cortisone acetate—Prednisolone—multiple sclerosis	0.00116	0.00719	CrCrCtD
Methylprednisolone—Prednicarbate—Prednisone—multiple sclerosis	0.00116	0.00715	CrCrCtD
Methylprednisolone—Testolactone—Prednisone—multiple sclerosis	0.00116	0.00715	CrCrCtD
Methylprednisolone—CYP3A4—Dexamethasone—multiple sclerosis	0.00115	0.0116	CbGbCtD
Methylprednisolone—Alclometasone—Triamcinolone—multiple sclerosis	0.00115	0.00711	CrCrCtD
Methylprednisolone—Fluocinolone Acetonide—Triamcinolone—multiple sclerosis	0.00115	0.00711	CrCrCtD
Methylprednisolone—Budesonide—Betamethasone—multiple sclerosis	0.00115	0.00709	CrCrCtD
Methylprednisolone—Budesonide—Dexamethasone—multiple sclerosis	0.00115	0.00709	CrCrCtD
Methylprednisolone—Prednicarbate—Prednisolone—multiple sclerosis	0.00113	0.00698	CrCrCtD
Methylprednisolone—Testolactone—Prednisolone—multiple sclerosis	0.00113	0.00698	CrCrCtD
Methylprednisolone—Clocortolone—Prednisolone—multiple sclerosis	0.00113	0.00698	CrCrCtD
Methylprednisolone—Fluocortolone—Prednisone—multiple sclerosis	0.00112	0.00694	CrCrCtD
Methylprednisolone—Budesonide—Triamcinolone—multiple sclerosis	0.00112	0.00692	CrCrCtD
Methylprednisolone—Prednisone—Betamethasone—multiple sclerosis	0.00112	0.0069	CrCrCtD
Methylprednisolone—Fludrocortisone—Betamethasone—multiple sclerosis	0.00112	0.0069	CrCrCtD
Methylprednisolone—Flunisolide—Betamethasone—multiple sclerosis	0.00112	0.0069	CrCrCtD
Methylprednisolone—Fludrocortisone—Dexamethasone—multiple sclerosis	0.00112	0.0069	CrCrCtD
Methylprednisolone—Diflorasone—Dexamethasone—multiple sclerosis	0.00112	0.0069	CrCrCtD
Methylprednisolone—Flunisolide—Dexamethasone—multiple sclerosis	0.00112	0.0069	CrCrCtD
Methylprednisolone—Diflorasone—Betamethasone—multiple sclerosis	0.00112	0.0069	CrCrCtD
Methylprednisolone—Prednisone—Dexamethasone—multiple sclerosis	0.00112	0.0069	CrCrCtD
Methylprednisolone—Desonide—Betamethasone—multiple sclerosis	0.00112	0.0069	CrCrCtD
Methylprednisolone—Clobetasol propionate—Dexamethasone—multiple sclerosis	0.00112	0.0069	CrCrCtD
Methylprednisolone—Clobetasol propionate—Betamethasone—multiple sclerosis	0.00112	0.0069	CrCrCtD
Methylprednisolone—Desonide—Dexamethasone—multiple sclerosis	0.00112	0.0069	CrCrCtD
Methylprednisolone—Fluocortolone—Prednisolone—multiple sclerosis	0.0011	0.00678	CrCrCtD
Methylprednisolone—Alclometasone—Prednisone—multiple sclerosis	0.00109	0.00675	CrCrCtD
Methylprednisolone—Desonide—Triamcinolone—multiple sclerosis	0.00109	0.00675	CrCrCtD
Methylprednisolone—Clobetasol propionate—Triamcinolone—multiple sclerosis	0.00109	0.00675	CrCrCtD
Methylprednisolone—Prednisone—Triamcinolone—multiple sclerosis	0.00109	0.00675	CrCrCtD
Methylprednisolone—Diflorasone—Triamcinolone—multiple sclerosis	0.00109	0.00675	CrCrCtD
Methylprednisolone—Flunisolide—Triamcinolone—multiple sclerosis	0.00109	0.00675	CrCrCtD
Methylprednisolone—Fludrocortisone—Triamcinolone—multiple sclerosis	0.00109	0.00675	CrCrCtD
Methylprednisolone—Paramethasone—Betamethasone—multiple sclerosis	0.00109	0.00673	CrCrCtD
Methylprednisolone—Paramethasone—Dexamethasone—multiple sclerosis	0.00109	0.00673	CrCrCtD
Methylprednisolone—Alclometasone—Prednisolone—multiple sclerosis	0.00107	0.00659	CrCrCtD
Methylprednisolone—Fluocinolone Acetonide—Prednisolone—multiple sclerosis	0.00107	0.00659	CrCrCtD
Methylprednisolone—Paramethasone—Triamcinolone—multiple sclerosis	0.00106	0.00658	CrCrCtD
Methylprednisolone—Budesonide—Prednisone—multiple sclerosis	0.00106	0.00657	CrCrCtD
Methylprednisolone—Desoximetasone—Betamethasone—multiple sclerosis	0.00106	0.00657	CrCrCtD
Methylprednisolone—Desoximetasone—Dexamethasone—multiple sclerosis	0.00106	0.00657	CrCrCtD
Methylprednisolone—Desoximetasone—Triamcinolone—multiple sclerosis	0.00104	0.00642	CrCrCtD
Methylprednisolone—Budesonide—Prednisolone—multiple sclerosis	0.00104	0.00641	CrCrCtD
Methylprednisolone—Triamcinolone—Dexamethasone—multiple sclerosis	0.00104	0.00641	CrCrCtD
Methylprednisolone—Fluprednidene Acetate—Betamethasone—multiple sclerosis	0.00104	0.00641	CrCrCtD
Methylprednisolone—Fluprednidene Acetate—Dexamethasone—multiple sclerosis	0.00104	0.00641	CrCrCtD
Methylprednisolone—Mometasone—Dexamethasone—multiple sclerosis	0.00104	0.00641	CrCrCtD
Methylprednisolone—Mometasone—Betamethasone—multiple sclerosis	0.00104	0.00641	CrCrCtD
Methylprednisolone—Loteprednol—Betamethasone—multiple sclerosis	0.00104	0.00641	CrCrCtD
Methylprednisolone—Triamcinolone—Betamethasone—multiple sclerosis	0.00104	0.00641	CrCrCtD
Methylprednisolone—Fluorometholone—Dexamethasone—multiple sclerosis	0.00104	0.00641	CrCrCtD
Methylprednisolone—Loteprednol—Dexamethasone—multiple sclerosis	0.00104	0.00641	CrCrCtD
Methylprednisolone—Fluorometholone—Betamethasone—multiple sclerosis	0.00104	0.00641	CrCrCtD
Methylprednisolone—Flunisolide—Prednisone—multiple sclerosis	0.00104	0.0064	CrCrCtD
Methylprednisolone—Diflorasone—Prednisone—multiple sclerosis	0.00104	0.0064	CrCrCtD
Methylprednisolone—Fludrocortisone—Prednisone—multiple sclerosis	0.00104	0.0064	CrCrCtD
Methylprednisolone—Desonide—Prednisone—multiple sclerosis	0.00104	0.0064	CrCrCtD
Methylprednisolone—Clobetasol propionate—Prednisone—multiple sclerosis	0.00104	0.0064	CrCrCtD
Methylprednisolone—Rimexolone—Betamethasone—multiple sclerosis	0.00101	0.00626	CrCrCtD
Methylprednisolone—Betamethasone—Dexamethasone—multiple sclerosis	0.00101	0.00626	CrCrCtD
Methylprednisolone—Dexamethasone—Betamethasone—multiple sclerosis	0.00101	0.00626	CrCrCtD
Methylprednisolone—Rimexolone—Dexamethasone—multiple sclerosis	0.00101	0.00626	CrCrCtD
Methylprednisolone—Fluorometholone—Triamcinolone—multiple sclerosis	0.00101	0.00626	CrCrCtD
Methylprednisolone—Mometasone—Triamcinolone—multiple sclerosis	0.00101	0.00626	CrCrCtD
Methylprednisolone—Fluprednidene Acetate—Triamcinolone—multiple sclerosis	0.00101	0.00626	CrCrCtD
Methylprednisolone—Loteprednol—Triamcinolone—multiple sclerosis	0.00101	0.00626	CrCrCtD
Methylprednisolone—Diflorasone—Prednisolone—multiple sclerosis	0.00101	0.00625	CrCrCtD
Methylprednisolone—Desonide—Prednisolone—multiple sclerosis	0.00101	0.00625	CrCrCtD
Methylprednisolone—Fludrocortisone—Prednisolone—multiple sclerosis	0.00101	0.00625	CrCrCtD
Methylprednisolone—Prednisone—Prednisolone—multiple sclerosis	0.00101	0.00625	CrCrCtD
Methylprednisolone—Flunisolide—Prednisolone—multiple sclerosis	0.00101	0.00625	CrCrCtD
Methylprednisolone—Clobetasol propionate—Prednisolone—multiple sclerosis	0.00101	0.00625	CrCrCtD
Methylprednisolone—Paramethasone—Prednisone—multiple sclerosis	0.00101	0.00624	CrCrCtD
Methylprednisolone—Betamethasone—Triamcinolone—multiple sclerosis	0.00099	0.00612	CrCrCtD
Methylprednisolone—Dexamethasone—Triamcinolone—multiple sclerosis	0.00099	0.00612	CrCrCtD
Methylprednisolone—Rimexolone—Triamcinolone—multiple sclerosis	0.00099	0.00612	CrCrCtD
Methylprednisolone—Paramethasone—Prednisolone—multiple sclerosis	0.000985	0.00609	CrCrCtD
Methylprednisolone—Desoximetasone—Prednisone—multiple sclerosis	0.000985	0.00609	CrCrCtD
Methylprednisolone—Fluorometholone—Prednisone—multiple sclerosis	0.000962	0.00595	CrCrCtD
Methylprednisolone—Fluprednidene Acetate—Prednisone—multiple sclerosis	0.000962	0.00595	CrCrCtD
Methylprednisolone—Triamcinolone—Prednisone—multiple sclerosis	0.000962	0.00595	CrCrCtD
Methylprednisolone—Mometasone—Prednisone—multiple sclerosis	0.000962	0.00595	CrCrCtD
Methylprednisolone—Loteprednol—Prednisone—multiple sclerosis	0.000962	0.00595	CrCrCtD
Methylprednisolone—Desoximetasone—Prednisolone—multiple sclerosis	0.000961	0.00594	CrCrCtD
Methylprednisolone—Prednisolone—Betamethasone—multiple sclerosis	0.000949	0.00587	CrCrCtD
Methylprednisolone—Prednisolone—Dexamethasone—multiple sclerosis	0.000949	0.00587	CrCrCtD
Methylprednisolone—Rimexolone—Prednisone—multiple sclerosis	0.00094	0.00581	CrCrCtD
Methylprednisolone—Betamethasone—Prednisone—multiple sclerosis	0.00094	0.00581	CrCrCtD
Methylprednisolone—Dexamethasone—Prednisone—multiple sclerosis	0.00094	0.00581	CrCrCtD
Methylprednisolone—Mometasone—Prednisolone—multiple sclerosis	0.000939	0.0058	CrCrCtD
Methylprednisolone—Fluorometholone—Prednisolone—multiple sclerosis	0.000939	0.0058	CrCrCtD
Methylprednisolone—Fluprednidene Acetate—Prednisolone—multiple sclerosis	0.000939	0.0058	CrCrCtD
Methylprednisolone—Loteprednol—Prednisolone—multiple sclerosis	0.000939	0.0058	CrCrCtD
Methylprednisolone—Triamcinolone—Prednisolone—multiple sclerosis	0.000939	0.0058	CrCrCtD
Methylprednisolone—Prednisolone—Triamcinolone—multiple sclerosis	0.000927	0.00573	CrCrCtD
Methylprednisolone—Dexamethasone—Prednisolone—multiple sclerosis	0.000917	0.00567	CrCrCtD
Methylprednisolone—Rimexolone—Prednisolone—multiple sclerosis	0.000917	0.00567	CrCrCtD
Methylprednisolone—Betamethasone—Prednisolone—multiple sclerosis	0.000917	0.00567	CrCrCtD
Methylprednisolone—Hydrocortisone—Dexamethasone—multiple sclerosis	0.000911	0.00563	CrCrCtD
Methylprednisolone—Hydrocortisone—Betamethasone—multiple sclerosis	0.000911	0.00563	CrCrCtD
Methylprednisolone—Hydrocortisone—Triamcinolone—multiple sclerosis	0.00089	0.0055	CrCrCtD
Methylprednisolone—Prednisolone—Prednisone—multiple sclerosis	0.00088	0.00544	CrCrCtD
Methylprednisolone—Hydrocortisone—Prednisone—multiple sclerosis	0.000844	0.00522	CrCrCtD
Methylprednisolone—Hydrocortisone—Prednisolone—multiple sclerosis	0.000824	0.0051	CrCrCtD
Methylprednisolone—Medroxyprogesterone Acetate—PGR—multiple sclerosis	6.3e-05	0.224	CrCbGaD
Methylprednisolone—Fluticasone Propionate—PGR—multiple sclerosis	6.25e-05	0.222	CrCbGaD
Methylprednisolone—Betamethasone—PGR—multiple sclerosis	5.72e-05	0.203	CrCbGaD
Methylprednisolone—Triamcinolone—BCHE—multiple sclerosis	4.78e-05	0.17	CrCbGaD
Methylprednisolone—NR3C1—Endoderm Differentiation—HHEX—multiple sclerosis	3.7e-05	0.0543	CbGpPWpGaD
Methylprednisolone—Dexamethasone—PGR—multiple sclerosis	3.33e-05	0.118	CrCbGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	2.24e-05	0.0329	CbGpPWpGaD
Methylprednisolone—NR3C1—Endoderm Differentiation—TBX21—multiple sclerosis	2.13e-05	0.0312	CbGpPWpGaD
Methylprednisolone—NR3C1—Endoderm Differentiation—EOMES—multiple sclerosis	2.13e-05	0.0312	CbGpPWpGaD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	1.99e-05	0.0292	CbGpPWpGaD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	1.99e-05	0.0292	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—TBX21—multiple sclerosis	1.83e-05	0.0268	CbGpPWpGaD
Methylprednisolone—Prednisone—ALB—multiple sclerosis	1.78e-05	0.0632	CrCbGaD
Methylprednisolone—NR3C1—Nuclear Receptors—PGR—multiple sclerosis	1.59e-05	0.0233	CbGpPWpGaD
Methylprednisolone—NR3C1—Endoderm Differentiation—PABPC1—multiple sclerosis	1.4e-05	0.0206	CbGpPWpGaD
Methylprednisolone—NR3C1—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	1.25e-05	0.0184	CbGpPWpGaD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	1.23e-05	0.018	CbGpPWpGaD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	1.23e-05	0.018	CbGpPWpGaD
Methylprednisolone—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	1.13e-05	0.0166	CbGpPWpGaD
Methylprednisolone—NR3C1—Nuclear Receptors—VDR—multiple sclerosis	1.11e-05	0.0162	CbGpPWpGaD
Methylprednisolone—Eye disorder—Betamethasone—multiple sclerosis	1.1e-05	0.000213	CcSEcCtD
Methylprednisolone—Paraesthesia—Mitoxantrone—multiple sclerosis	1.09e-05	0.000212	CcSEcCtD
Methylprednisolone—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	1.09e-05	0.0159	CbGpPWpGaD
Methylprednisolone—Loss of consciousness—Prednisolone—multiple sclerosis	1.08e-05	0.000209	CcSEcCtD
Methylprednisolone—Dyspepsia—Mitoxantrone—multiple sclerosis	1.07e-05	0.000208	CcSEcCtD
Methylprednisolone—Angiopathy—Dexamethasone—multiple sclerosis	1.07e-05	0.000207	CcSEcCtD
Methylprednisolone—Angiopathy—Betamethasone—multiple sclerosis	1.07e-05	0.000207	CcSEcCtD
Methylprednisolone—Convulsion—Prednisolone—multiple sclerosis	1.06e-05	0.000206	CcSEcCtD
Methylprednisolone—Hypertension—Prednisolone—multiple sclerosis	1.06e-05	0.000205	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—SELE—multiple sclerosis	1.05e-05	0.0154	CbGpPWpGaD
Methylprednisolone—Fatigue—Mitoxantrone—multiple sclerosis	1.05e-05	0.000204	CcSEcCtD
Methylprednisolone—Arrhythmia—Betamethasone—multiple sclerosis	1.05e-05	0.000204	CcSEcCtD
Methylprednisolone—Arrhythmia—Dexamethasone—multiple sclerosis	1.05e-05	0.000204	CcSEcCtD
Methylprednisolone—Pancreatitis—Methotrexate—multiple sclerosis	1.05e-05	0.000203	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Triamcinolone—multiple sclerosis	1.05e-05	0.000203	CcSEcCtD
Methylprednisolone—Bradycardia—Prednisone—multiple sclerosis	1.04e-05	0.000202	CcSEcCtD
Methylprednisolone—Diarrhoea—Azathioprine—multiple sclerosis	1.03e-05	0.0002	CcSEcCtD
Methylprednisolone—Discomfort—Prednisolone—multiple sclerosis	1.03e-05	0.0002	CcSEcCtD
Methylprednisolone—Angioedema—Triamcinolone—multiple sclerosis	1.03e-05	0.0002	CcSEcCtD
Methylprednisolone—Haemoglobin—Prednisone—multiple sclerosis	1.03e-05	0.000199	CcSEcCtD
Methylprednisolone—Haemorrhage—Prednisone—multiple sclerosis	1.02e-05	0.000198	CcSEcCtD
Methylprednisolone—Erythema—Dexamethasone—multiple sclerosis	1.02e-05	0.000198	CcSEcCtD
Methylprednisolone—Erythema—Betamethasone—multiple sclerosis	1.02e-05	0.000198	CcSEcCtD
Methylprednisolone—Hallucination—Prednisone—multiple sclerosis	1.02e-05	0.000197	CcSEcCtD
Methylprednisolone—Malaise—Triamcinolone—multiple sclerosis	1.02e-05	0.000197	CcSEcCtD
Methylprednisolone—Vertigo—Triamcinolone—multiple sclerosis	1.01e-05	0.000196	CcSEcCtD
Methylprednisolone—Syncope—Triamcinolone—multiple sclerosis	1.01e-05	0.000196	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Prednisone—multiple sclerosis	1.01e-05	0.000195	CcSEcCtD
Methylprednisolone—Feeling abnormal—Mitoxantrone—multiple sclerosis	1e-05	0.000195	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Prednisolone—multiple sclerosis	1e-05	0.000194	CcSEcCtD
Methylprednisolone—Dizziness—Azathioprine—multiple sclerosis	9.97e-06	0.000193	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	9.97e-06	0.000193	CcSEcCtD
Methylprednisolone—Loss of consciousness—Triamcinolone—multiple sclerosis	9.91e-06	0.000192	CcSEcCtD
Methylprednisolone—Shock—Prednisolone—multiple sclerosis	9.84e-06	0.000191	CcSEcCtD
Methylprednisolone—Convulsion—Triamcinolone—multiple sclerosis	9.77e-06	0.000189	CcSEcCtD
Methylprednisolone—Tachycardia—Prednisolone—multiple sclerosis	9.76e-06	0.000189	CcSEcCtD
Methylprednisolone—Hypertension—Triamcinolone—multiple sclerosis	9.73e-06	0.000189	CcSEcCtD
Methylprednisolone—Urticaria—Mitoxantrone—multiple sclerosis	9.69e-06	0.000188	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Prednisolone—multiple sclerosis	9.67e-06	0.000188	CcSEcCtD
Methylprednisolone—Abdominal pain—Mitoxantrone—multiple sclerosis	9.64e-06	0.000187	CcSEcCtD
Methylprednisolone—Myalgia—Triamcinolone—multiple sclerosis	9.6e-06	0.000186	CcSEcCtD
Methylprednisolone—Vomiting—Azathioprine—multiple sclerosis	9.59e-06	0.000186	CcSEcCtD
Methylprednisolone—Eye disorder—Prednisone—multiple sclerosis	9.56e-06	0.000185	CcSEcCtD
Methylprednisolone—Infestation NOS—Methotrexate—multiple sclerosis	9.53e-06	0.000185	CcSEcCtD
Methylprednisolone—Infestation—Methotrexate—multiple sclerosis	9.53e-06	0.000185	CcSEcCtD
Methylprednisolone—Rash—Azathioprine—multiple sclerosis	9.51e-06	0.000184	CcSEcCtD
Methylprednisolone—Dermatitis—Azathioprine—multiple sclerosis	9.5e-06	0.000184	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Betamethasone—multiple sclerosis	9.49e-06	0.000184	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Dexamethasone—multiple sclerosis	9.49e-06	0.000184	CcSEcCtD
Methylprednisolone—Discomfort—Triamcinolone—multiple sclerosis	9.48e-06	0.000184	CcSEcCtD
Methylprednisolone—Headache—Azathioprine—multiple sclerosis	9.45e-06	0.000183	CcSEcCtD
Methylprednisolone—Angioedema—Dexamethasone—multiple sclerosis	9.35e-06	0.000181	CcSEcCtD
Methylprednisolone—Angioedema—Betamethasone—multiple sclerosis	9.35e-06	0.000181	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	9.31e-06	0.0136	CbGpPWpGaD
Methylprednisolone—Angiopathy—Prednisone—multiple sclerosis	9.28e-06	0.00018	CcSEcCtD
Methylprednisolone—Immune system disorder—Prednisone—multiple sclerosis	9.24e-06	0.000179	CcSEcCtD
Methylprednisolone—Malaise—Betamethasone—multiple sclerosis	9.22e-06	0.000179	CcSEcCtD
Methylprednisolone—Malaise—Dexamethasone—multiple sclerosis	9.22e-06	0.000179	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Triamcinolone—multiple sclerosis	9.2e-06	0.000178	CcSEcCtD
Methylprednisolone—Vertigo—Betamethasone—multiple sclerosis	9.19e-06	0.000178	CcSEcCtD
Methylprednisolone—Vertigo—Dexamethasone—multiple sclerosis	9.19e-06	0.000178	CcSEcCtD
Methylprednisolone—Syncope—Dexamethasone—multiple sclerosis	9.17e-06	0.000178	CcSEcCtD
Methylprednisolone—Syncope—Betamethasone—multiple sclerosis	9.17e-06	0.000178	CcSEcCtD
Methylprednisolone—Arrhythmia—Prednisone—multiple sclerosis	9.14e-06	0.000177	CcSEcCtD
Methylprednisolone—Infection—Triamcinolone—multiple sclerosis	9.14e-06	0.000177	CcSEcCtD
Methylprednisolone—Sweating—Methotrexate—multiple sclerosis	9.13e-06	0.000177	CcSEcCtD
Methylprednisolone—Shock—Triamcinolone—multiple sclerosis	9.05e-06	0.000176	CcSEcCtD
Methylprednisolone—Insomnia—Prednisolone—multiple sclerosis	9.05e-06	0.000176	CcSEcCtD
Methylprednisolone—Loss of consciousness—Betamethasone—multiple sclerosis	8.99e-06	0.000174	CcSEcCtD
Methylprednisolone—Loss of consciousness—Dexamethasone—multiple sclerosis	8.99e-06	0.000174	CcSEcCtD
Methylprednisolone—Hypersensitivity—Mitoxantrone—multiple sclerosis	8.98e-06	0.000174	CcSEcCtD
Methylprednisolone—Paraesthesia—Prednisolone—multiple sclerosis	8.98e-06	0.000174	CcSEcCtD
Methylprednisolone—Tachycardia—Triamcinolone—multiple sclerosis	8.98e-06	0.000174	CcSEcCtD
Methylprednisolone—Mental disorder—Prednisone—multiple sclerosis	8.96e-06	0.000174	CcSEcCtD
Methylprednisolone—Nausea—Azathioprine—multiple sclerosis	8.96e-06	0.000174	CcSEcCtD
Methylprednisolone—Malnutrition—Prednisone—multiple sclerosis	8.91e-06	0.000173	CcSEcCtD
Methylprednisolone—Erythema—Prednisone—multiple sclerosis	8.91e-06	0.000173	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Triamcinolone—multiple sclerosis	8.89e-06	0.000173	CcSEcCtD
Methylprednisolone—Convulsion—Dexamethasone—multiple sclerosis	8.86e-06	0.000172	CcSEcCtD
Methylprednisolone—Convulsion—Betamethasone—multiple sclerosis	8.86e-06	0.000172	CcSEcCtD
Methylprednisolone—Hypertension—Dexamethasone—multiple sclerosis	8.83e-06	0.000171	CcSEcCtD
Methylprednisolone—Hypertension—Betamethasone—multiple sclerosis	8.83e-06	0.000171	CcSEcCtD
Methylprednisolone—NR3C1—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	8.76e-06	0.0128	CbGpPWpGaD
Methylprednisolone—Asthenia—Mitoxantrone—multiple sclerosis	8.75e-06	0.00017	CcSEcCtD
Methylprednisolone—Myalgia—Betamethasone—multiple sclerosis	8.71e-06	0.000169	CcSEcCtD
Methylprednisolone—Myalgia—Dexamethasone—multiple sclerosis	8.71e-06	0.000169	CcSEcCtD
Methylprednisolone—Anxiety—Betamethasone—multiple sclerosis	8.68e-06	0.000168	CcSEcCtD
Methylprednisolone—Anxiety—Dexamethasone—multiple sclerosis	8.68e-06	0.000168	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—C4A—multiple sclerosis	8.62e-06	0.0126	CbGpPWpGaD
Methylprednisolone—Discomfort—Dexamethasone—multiple sclerosis	8.6e-06	0.000167	CcSEcCtD
Methylprednisolone—Discomfort—Betamethasone—multiple sclerosis	8.6e-06	0.000167	CcSEcCtD
Methylprednisolone—Haemoglobin—Methotrexate—multiple sclerosis	8.59e-06	0.000167	CcSEcCtD
Methylprednisolone—Haemorrhage—Methotrexate—multiple sclerosis	8.55e-06	0.000166	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	8.38e-06	0.000163	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Betamethasone—multiple sclerosis	8.35e-06	0.000162	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Dexamethasone—multiple sclerosis	8.35e-06	0.000162	CcSEcCtD
Methylprednisolone—Diarrhoea—Mitoxantrone—multiple sclerosis	8.34e-06	0.000162	CcSEcCtD
Methylprednisolone—Insomnia—Triamcinolone—multiple sclerosis	8.32e-06	0.000161	CcSEcCtD
Methylprednisolone—Infection—Betamethasone—multiple sclerosis	8.29e-06	0.000161	CcSEcCtD
Methylprednisolone—Infection—Dexamethasone—multiple sclerosis	8.29e-06	0.000161	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Prednisone—multiple sclerosis	8.26e-06	0.00016	CcSEcCtD
Methylprednisolone—Paraesthesia—Triamcinolone—multiple sclerosis	8.26e-06	0.00016	CcSEcCtD
Methylprednisolone—Feeling abnormal—Prednisolone—multiple sclerosis	8.24e-06	0.00016	CcSEcCtD
Methylprednisolone—Visual impairment—Methotrexate—multiple sclerosis	8.24e-06	0.00016	CcSEcCtD
Methylprednisolone—Shock—Betamethasone—multiple sclerosis	8.21e-06	0.000159	CcSEcCtD
Methylprednisolone—Shock—Dexamethasone—multiple sclerosis	8.21e-06	0.000159	CcSEcCtD
Methylprednisolone—Nervous system disorder—Dexamethasone—multiple sclerosis	8.19e-06	0.000159	CcSEcCtD
Methylprednisolone—Nervous system disorder—Betamethasone—multiple sclerosis	8.19e-06	0.000159	CcSEcCtD
Methylprednisolone—Tachycardia—Betamethasone—multiple sclerosis	8.15e-06	0.000158	CcSEcCtD
Methylprednisolone—Tachycardia—Dexamethasone—multiple sclerosis	8.15e-06	0.000158	CcSEcCtD
Methylprednisolone—Angioedema—Prednisone—multiple sclerosis	8.14e-06	0.000158	CcSEcCtD
Methylprednisolone—Dyspepsia—Triamcinolone—multiple sclerosis	8.1e-06	0.000157	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Dexamethasone—multiple sclerosis	8.07e-06	0.000157	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Betamethasone—multiple sclerosis	8.07e-06	0.000157	CcSEcCtD
Methylprednisolone—Malaise—Prednisone—multiple sclerosis	8.03e-06	0.000156	CcSEcCtD
Methylprednisolone—Vertigo—Prednisone—multiple sclerosis	8e-06	0.000155	CcSEcCtD
Methylprednisolone—Eye disorder—Methotrexate—multiple sclerosis	7.99e-06	0.000155	CcSEcCtD
Methylprednisolone—Syncope—Prednisone—multiple sclerosis	7.99e-06	0.000155	CcSEcCtD
Methylprednisolone—Urticaria—Prednisolone—multiple sclerosis	7.95e-06	0.000154	CcSEcCtD
Methylprednisolone—Cardiac disorder—Methotrexate—multiple sclerosis	7.94e-06	0.000154	CcSEcCtD
Methylprednisolone—Fatigue—Triamcinolone—multiple sclerosis	7.93e-06	0.000154	CcSEcCtD
Methylprednisolone—Loss of consciousness—Prednisone—multiple sclerosis	7.83e-06	0.000152	CcSEcCtD
Methylprednisolone—Hypotension—Dexamethasone—multiple sclerosis	7.8e-06	0.000151	CcSEcCtD
Methylprednisolone—Hypotension—Betamethasone—multiple sclerosis	7.8e-06	0.000151	CcSEcCtD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	7.78e-06	0.0114	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	7.78e-06	0.0114	CbGpPWpGaD
Methylprednisolone—Angiopathy—Methotrexate—multiple sclerosis	7.76e-06	0.00015	CcSEcCtD
Methylprednisolone—Vomiting—Mitoxantrone—multiple sclerosis	7.75e-06	0.00015	CcSEcCtD
Methylprednisolone—Immune system disorder—Methotrexate—multiple sclerosis	7.72e-06	0.00015	CcSEcCtD
Methylprednisolone—Convulsion—Prednisone—multiple sclerosis	7.72e-06	0.00015	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Methotrexate—multiple sclerosis	7.71e-06	0.000149	CcSEcCtD
Methylprednisolone—Hypertension—Prednisone—multiple sclerosis	7.69e-06	0.000149	CcSEcCtD
Methylprednisolone—Rash—Mitoxantrone—multiple sclerosis	7.69e-06	0.000149	CcSEcCtD
Methylprednisolone—Dermatitis—Mitoxantrone—multiple sclerosis	7.68e-06	0.000149	CcSEcCtD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	7.68e-06	0.0113	CbGpPWpGaD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	7.68e-06	0.0113	CbGpPWpGaD
Methylprednisolone—Headache—Mitoxantrone—multiple sclerosis	7.64e-06	0.000148	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	7.62e-06	0.0112	CbGpPWpGaD
Methylprednisolone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	7.61e-06	0.000148	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	7.61e-06	0.000148	CcSEcCtD
Methylprednisolone—Myalgia—Prednisone—multiple sclerosis	7.58e-06	0.000147	CcSEcCtD
Methylprednisolone—Arthralgia—Prednisone—multiple sclerosis	7.58e-06	0.000147	CcSEcCtD
Methylprednisolone—Feeling abnormal—Triamcinolone—multiple sclerosis	7.58e-06	0.000147	CcSEcCtD
Methylprednisolone—Anxiety—Prednisone—multiple sclerosis	7.56e-06	0.000147	CcSEcCtD
Methylprednisolone—Insomnia—Betamethasone—multiple sclerosis	7.55e-06	0.000146	CcSEcCtD
Methylprednisolone—Insomnia—Dexamethasone—multiple sclerosis	7.55e-06	0.000146	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	7.53e-06	0.000146	CcSEcCtD
Methylprednisolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—multiple sclerosis	7.51e-06	0.011	CbGpPWpGaD
Methylprednisolone—Paraesthesia—Dexamethasone—multiple sclerosis	7.5e-06	0.000145	CcSEcCtD
Methylprednisolone—Paraesthesia—Betamethasone—multiple sclerosis	7.5e-06	0.000145	CcSEcCtD
Methylprednisolone—Discomfort—Prednisone—multiple sclerosis	7.49e-06	0.000145	CcSEcCtD
Methylprednisolone—Mental disorder—Methotrexate—multiple sclerosis	7.49e-06	0.000145	CcSEcCtD
Methylprednisolone—Malnutrition—Methotrexate—multiple sclerosis	7.44e-06	0.000144	CcSEcCtD
Methylprednisolone—Erythema—Methotrexate—multiple sclerosis	7.44e-06	0.000144	CcSEcCtD
Methylprednisolone—Hypersensitivity—Prednisolone—multiple sclerosis	7.37e-06	0.000143	CcSEcCtD
Methylprednisolone—Dyspepsia—Betamethasone—multiple sclerosis	7.35e-06	0.000143	CcSEcCtD
Methylprednisolone—Dyspepsia—Dexamethasone—multiple sclerosis	7.35e-06	0.000143	CcSEcCtD
Methylprednisolone—Urticaria—Triamcinolone—multiple sclerosis	7.31e-06	0.000142	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Prednisone—multiple sclerosis	7.27e-06	0.000141	CcSEcCtD
Methylprednisolone—Nausea—Mitoxantrone—multiple sclerosis	7.24e-06	0.00014	CcSEcCtD
Methylprednisolone—Infection—Prednisone—multiple sclerosis	7.22e-06	0.00014	CcSEcCtD
Methylprednisolone—Fatigue—Dexamethasone—multiple sclerosis	7.2e-06	0.00014	CcSEcCtD
Methylprednisolone—Fatigue—Betamethasone—multiple sclerosis	7.2e-06	0.00014	CcSEcCtD
Methylprednisolone—NR3C1—Generic Transcription Pathway—ZNF746—multiple sclerosis	7.18e-06	0.0105	CbGpPWpGaD
Methylprednisolone—Shock—Prednisone—multiple sclerosis	7.15e-06	0.000139	CcSEcCtD
Methylprednisolone—Nervous system disorder—Prednisone—multiple sclerosis	7.13e-06	0.000138	CcSEcCtD
Methylprednisolone—Tachycardia—Prednisone—multiple sclerosis	7.09e-06	0.000138	CcSEcCtD
Methylprednisolone—Skin disorder—Prednisone—multiple sclerosis	7.06e-06	0.000137	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	7.06e-06	0.0103	CbGpPWpGaD
Methylprednisolone—Hyperhidrosis—Prednisone—multiple sclerosis	7.03e-06	0.000136	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	7.03e-06	0.0103	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	7.03e-06	0.0103	CbGpPWpGaD
Methylprednisolone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	6.98e-06	0.0102	CbGpPWpGaD
Methylprednisolone—Ill-defined disorder—Methotrexate—multiple sclerosis	6.91e-06	0.000134	CcSEcCtD
Methylprednisolone—Feeling abnormal—Dexamethasone—multiple sclerosis	6.88e-06	0.000133	CcSEcCtD
Methylprednisolone—Feeling abnormal—Betamethasone—multiple sclerosis	6.88e-06	0.000133	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Betamethasone—multiple sclerosis	6.83e-06	0.000132	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	6.83e-06	0.000132	CcSEcCtD
Methylprednisolone—Hypersensitivity—Triamcinolone—multiple sclerosis	6.78e-06	0.000131	CcSEcCtD
Methylprednisolone—Malaise—Methotrexate—multiple sclerosis	6.71e-06	0.00013	CcSEcCtD
Methylprednisolone—Vertigo—Methotrexate—multiple sclerosis	6.69e-06	0.00013	CcSEcCtD
Methylprednisolone—Urticaria—Betamethasone—multiple sclerosis	6.63e-06	0.000129	CcSEcCtD
Methylprednisolone—Urticaria—Dexamethasone—multiple sclerosis	6.63e-06	0.000129	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	6.62e-06	0.000128	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IL10—multiple sclerosis	6.62e-06	0.0097	CbGpPWpGaD
Methylprednisolone—Dizziness—Prednisolone—multiple sclerosis	6.62e-06	0.000128	CcSEcCtD
Methylprednisolone—Asthenia—Triamcinolone—multiple sclerosis	6.6e-06	0.000128	CcSEcCtD
Methylprednisolone—Abdominal pain—Betamethasone—multiple sclerosis	6.6e-06	0.000128	CcSEcCtD
Methylprednisolone—Abdominal pain—Dexamethasone—multiple sclerosis	6.6e-06	0.000128	CcSEcCtD
Methylprednisolone—Insomnia—Prednisone—multiple sclerosis	6.57e-06	0.000128	CcSEcCtD
Methylprednisolone—Paraesthesia—Prednisone—multiple sclerosis	6.53e-06	0.000127	CcSEcCtD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	6.51e-06	0.00954	CbGpPWpGaD
Methylprednisolone—Pruritus—Triamcinolone—multiple sclerosis	6.51e-06	0.000126	CcSEcCtD
Methylprednisolone—Convulsion—Methotrexate—multiple sclerosis	6.45e-06	0.000125	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IL4—multiple sclerosis	6.44e-06	0.00943	CbGpPWpGaD
Methylprednisolone—Dyspepsia—Prednisone—multiple sclerosis	6.4e-06	0.000124	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	6.39e-06	0.00937	CbGpPWpGaD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	6.36e-06	0.00932	CbGpPWpGaD
Methylprednisolone—Arthralgia—Methotrexate—multiple sclerosis	6.34e-06	0.000123	CcSEcCtD
Methylprednisolone—Myalgia—Methotrexate—multiple sclerosis	6.34e-06	0.000123	CcSEcCtD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	6.31e-06	0.00925	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	6.31e-06	0.00925	CbGpPWpGaD
Methylprednisolone—Rash—Prednisolone—multiple sclerosis	6.31e-06	0.000122	CcSEcCtD
Methylprednisolone—Dermatitis—Prednisolone—multiple sclerosis	6.3e-06	0.000122	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	6.29e-06	0.000122	CcSEcCtD
Methylprednisolone—Fatigue—Prednisone—multiple sclerosis	6.27e-06	0.000122	CcSEcCtD
Methylprednisolone—Headache—Prednisolone—multiple sclerosis	6.27e-06	0.000122	CcSEcCtD
Methylprednisolone—Discomfort—Methotrexate—multiple sclerosis	6.26e-06	0.000121	CcSEcCtD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	6.18e-06	0.00906	CbGpPWpGaD
Methylprednisolone—Confusional state—Methotrexate—multiple sclerosis	6.13e-06	0.000119	CcSEcCtD
Methylprednisolone—Dizziness—Triamcinolone—multiple sclerosis	6.08e-06	0.000118	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Methotrexate—multiple sclerosis	6.08e-06	0.000118	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	6.05e-06	0.00887	CbGpPWpGaD
Methylprednisolone—Infection—Methotrexate—multiple sclerosis	6.04e-06	0.000117	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	6.03e-06	0.00884	CbGpPWpGaD
Methylprednisolone—Feeling abnormal—Prednisone—multiple sclerosis	5.99e-06	0.000116	CcSEcCtD
Methylprednisolone—Asthenia—Dexamethasone—multiple sclerosis	5.99e-06	0.000116	CcSEcCtD
Methylprednisolone—Asthenia—Betamethasone—multiple sclerosis	5.99e-06	0.000116	CcSEcCtD
Methylprednisolone—Nervous system disorder—Methotrexate—multiple sclerosis	5.96e-06	0.000116	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Prednisone—multiple sclerosis	5.94e-06	0.000115	CcSEcCtD
Methylprednisolone—Nausea—Prednisolone—multiple sclerosis	5.94e-06	0.000115	CcSEcCtD
Methylprednisolone—Pruritus—Betamethasone—multiple sclerosis	5.91e-06	0.000115	CcSEcCtD
Methylprednisolone—Pruritus—Dexamethasone—multiple sclerosis	5.91e-06	0.000115	CcSEcCtD
Methylprednisolone—Skin disorder—Methotrexate—multiple sclerosis	5.9e-06	0.000114	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	5.89e-06	0.00863	CbGpPWpGaD
Methylprednisolone—Hyperhidrosis—Methotrexate—multiple sclerosis	5.87e-06	0.000114	CcSEcCtD
Methylprednisolone—Vomiting—Triamcinolone—multiple sclerosis	5.85e-06	0.000113	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—HLA-A—multiple sclerosis	5.83e-06	0.00855	CbGpPWpGaD
Methylprednisolone—Rash—Triamcinolone—multiple sclerosis	5.8e-06	0.000113	CcSEcCtD
Methylprednisolone—Dermatitis—Triamcinolone—multiple sclerosis	5.8e-06	0.000112	CcSEcCtD
Methylprednisolone—Urticaria—Prednisone—multiple sclerosis	5.77e-06	0.000112	CcSEcCtD
Methylprednisolone—Headache—Triamcinolone—multiple sclerosis	5.76e-06	0.000112	CcSEcCtD
Methylprednisolone—Abdominal pain—Prednisone—multiple sclerosis	5.75e-06	0.000111	CcSEcCtD
Methylprednisolone—Diarrhoea—Dexamethasone—multiple sclerosis	5.71e-06	0.000111	CcSEcCtD
Methylprednisolone—Diarrhoea—Betamethasone—multiple sclerosis	5.71e-06	0.000111	CcSEcCtD
Methylprednisolone—Hypotension—Methotrexate—multiple sclerosis	5.68e-06	0.00011	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL4—multiple sclerosis	5.67e-06	0.00831	CbGpPWpGaD
Methylprednisolone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	5.54e-06	0.000107	CcSEcCtD
Methylprednisolone—Dizziness—Dexamethasone—multiple sclerosis	5.52e-06	0.000107	CcSEcCtD
Methylprednisolone—Dizziness—Betamethasone—multiple sclerosis	5.52e-06	0.000107	CcSEcCtD
Methylprednisolone—Insomnia—Methotrexate—multiple sclerosis	5.49e-06	0.000107	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	5.47e-06	0.00802	CbGpPWpGaD
Methylprednisolone—Nausea—Triamcinolone—multiple sclerosis	5.46e-06	0.000106	CcSEcCtD
Methylprednisolone—Paraesthesia—Methotrexate—multiple sclerosis	5.46e-06	0.000106	CcSEcCtD
Methylprednisolone—Hypersensitivity—Prednisone—multiple sclerosis	5.36e-06	0.000104	CcSEcCtD
Methylprednisolone—Dyspepsia—Methotrexate—multiple sclerosis	5.35e-06	0.000104	CcSEcCtD
Methylprednisolone—Vomiting—Betamethasone—multiple sclerosis	5.31e-06	0.000103	CcSEcCtD
Methylprednisolone—Vomiting—Dexamethasone—multiple sclerosis	5.31e-06	0.000103	CcSEcCtD
Methylprednisolone—Rash—Betamethasone—multiple sclerosis	5.26e-06	0.000102	CcSEcCtD
Methylprednisolone—Rash—Dexamethasone—multiple sclerosis	5.26e-06	0.000102	CcSEcCtD
Methylprednisolone—Dermatitis—Betamethasone—multiple sclerosis	5.26e-06	0.000102	CcSEcCtD
Methylprednisolone—Dermatitis—Dexamethasone—multiple sclerosis	5.26e-06	0.000102	CcSEcCtD
Methylprednisolone—Fatigue—Methotrexate—multiple sclerosis	5.24e-06	0.000102	CcSEcCtD
Methylprednisolone—Headache—Betamethasone—multiple sclerosis	5.23e-06	0.000101	CcSEcCtD
Methylprednisolone—Headache—Dexamethasone—multiple sclerosis	5.23e-06	0.000101	CcSEcCtD
Methylprednisolone—Asthenia—Prednisone—multiple sclerosis	5.22e-06	0.000101	CcSEcCtD
Methylprednisolone—Pruritus—Prednisone—multiple sclerosis	5.14e-06	9.98e-05	CcSEcCtD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	5.13e-06	0.00752	CbGpPWpGaD
Methylprednisolone—Feeling abnormal—Methotrexate—multiple sclerosis	5.01e-06	9.71e-05	CcSEcCtD
Methylprednisolone—Diarrhoea—Prednisone—multiple sclerosis	4.97e-06	9.65e-05	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.97e-06	9.64e-05	CcSEcCtD
Methylprednisolone—Nausea—Dexamethasone—multiple sclerosis	4.96e-06	9.62e-05	CcSEcCtD
Methylprednisolone—Nausea—Betamethasone—multiple sclerosis	4.96e-06	9.62e-05	CcSEcCtD
Methylprednisolone—Urticaria—Methotrexate—multiple sclerosis	4.83e-06	9.36e-05	CcSEcCtD
Methylprednisolone—Dizziness—Prednisone—multiple sclerosis	4.81e-06	9.32e-05	CcSEcCtD
Methylprednisolone—Abdominal pain—Methotrexate—multiple sclerosis	4.8e-06	9.32e-05	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	4.75e-06	0.00696	CbGpPWpGaD
Methylprednisolone—Vomiting—Prednisone—multiple sclerosis	4.62e-06	8.97e-05	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—CD28—multiple sclerosis	4.61e-06	0.00676	CbGpPWpGaD
Methylprednisolone—Rash—Prednisone—multiple sclerosis	4.58e-06	8.89e-05	CcSEcCtD
Methylprednisolone—Dermatitis—Prednisone—multiple sclerosis	4.58e-06	8.88e-05	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CCL2—multiple sclerosis	4.57e-06	0.00671	CbGpPWpGaD
Methylprednisolone—Headache—Prednisone—multiple sclerosis	4.55e-06	8.83e-05	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	4.5e-06	0.0066	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Methotrexate—multiple sclerosis	4.48e-06	8.68e-05	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	4.41e-06	0.00647	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	4.38e-06	0.00641	CbGpPWpGaD
Methylprednisolone—Asthenia—Methotrexate—multiple sclerosis	4.36e-06	8.45e-05	CcSEcCtD
Methylprednisolone—Nausea—Prednisone—multiple sclerosis	4.32e-06	8.38e-05	CcSEcCtD
Methylprednisolone—Pruritus—Methotrexate—multiple sclerosis	4.3e-06	8.34e-05	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—CD40—multiple sclerosis	4.21e-06	0.00617	CbGpPWpGaD
Methylprednisolone—Diarrhoea—Methotrexate—multiple sclerosis	4.16e-06	8.06e-05	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	4.15e-06	0.00608	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	4.12e-06	0.00604	CbGpPWpGaD
Methylprednisolone—Dizziness—Methotrexate—multiple sclerosis	4.02e-06	7.79e-05	CcSEcCtD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	4.01e-06	0.00588	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IFNG—multiple sclerosis	3.89e-06	0.0057	CbGpPWpGaD
Methylprednisolone—Vomiting—Methotrexate—multiple sclerosis	3.86e-06	7.49e-05	CcSEcCtD
Methylprednisolone—Rash—Methotrexate—multiple sclerosis	3.83e-06	7.43e-05	CcSEcCtD
Methylprednisolone—Dermatitis—Methotrexate—multiple sclerosis	3.83e-06	7.42e-05	CcSEcCtD
Methylprednisolone—Headache—Methotrexate—multiple sclerosis	3.81e-06	7.38e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	3.79e-06	0.00556	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	3.65e-06	0.00535	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	3.65e-06	0.00535	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—FAS—multiple sclerosis	3.61e-06	0.0053	CbGpPWpGaD
Methylprednisolone—Nausea—Methotrexate—multiple sclerosis	3.61e-06	7e-05	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	3.48e-06	0.00511	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IL2—multiple sclerosis	3.46e-06	0.00507	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ZNF746—multiple sclerosis	3.46e-06	0.00507	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	3.43e-06	0.00502	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	3.42e-06	0.00501	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	3.35e-06	0.00491	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	3.35e-06	0.00491	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	3.31e-06	0.00484	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	3.31e-06	0.00484	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CD86—multiple sclerosis	3.29e-06	0.00482	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—MMP9—multiple sclerosis	3.27e-06	0.0048	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	3.23e-06	0.00473	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL10—multiple sclerosis	3.23e-06	0.00473	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PTBP1—multiple sclerosis	3.16e-06	0.00463	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL4—multiple sclerosis	3.14e-06	0.0046	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	3.07e-06	0.0045	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	3.05e-06	0.00446	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—FAS—multiple sclerosis	2.89e-06	0.00424	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	2.88e-06	0.00421	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	2.84e-06	0.00417	CbGpPWpGaD
Methylprednisolone—NR3C1—Endoderm Differentiation—TGFB1—multiple sclerosis	2.76e-06	0.00404	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—MYC—multiple sclerosis	2.7e-06	0.00396	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—TGFB1—multiple sclerosis	2.7e-06	0.00395	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	2.6e-06	0.00381	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	2.41e-06	0.00353	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CD80—multiple sclerosis	2.4e-06	0.00352	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—U2AF2—multiple sclerosis	2.4e-06	0.00351	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—HNRNPA1—multiple sclerosis	2.4e-06	0.00351	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	2.33e-06	0.00341	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—PGR—multiple sclerosis	2.17e-06	0.00317	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.14e-06	0.00313	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	2.08e-06	0.00304	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IL6—multiple sclerosis	2.03e-06	0.00298	CbGpPWpGaD
Methylprednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	1.93e-06	0.00283	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	1.9e-06	0.00278	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ZFP36L1—multiple sclerosis	1.89e-06	0.00278	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	1.83e-06	0.00268	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	1.79e-06	0.00262	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—STAT3—multiple sclerosis	1.77e-06	0.0026	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.75e-06	0.00257	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	1.69e-06	0.00248	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL2—multiple sclerosis	1.69e-06	0.00247	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.67e-06	0.00244	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—TGFB1—multiple sclerosis	1.64e-06	0.00241	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.62e-06	0.00237	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—TNF—multiple sclerosis	1.53e-06	0.00225	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—VDR—multiple sclerosis	1.51e-06	0.00222	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PABPC1—multiple sclerosis	1.47e-06	0.00215	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.43e-06	0.00209	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.42e-06	0.00208	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.33e-06	0.00194	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RPL5—multiple sclerosis	1.32e-06	0.00194	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SRM—multiple sclerosis	1.32e-06	0.00194	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	1.31e-06	0.00193	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.28e-06	0.00188	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—IL6—multiple sclerosis	1.24e-06	0.00181	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.23e-06	0.0018	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.13e-06	0.00166	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.07e-06	0.00157	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PGR—multiple sclerosis	1.04e-06	0.00153	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP27B1—multiple sclerosis	9.3e-07	0.00136	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP24A1—multiple sclerosis	9.3e-07	0.00136	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GPC5—multiple sclerosis	8.51e-07	0.00125	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SRM—multiple sclerosis	8.13e-07	0.00119	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	7.54e-07	0.0011	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—VDR—multiple sclerosis	7.29e-07	0.00107	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—RRM1—multiple sclerosis	7.05e-07	0.00103	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	6.5e-07	0.000953	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	6.49e-07	0.000951	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	6.36e-07	0.000933	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	6.06e-07	0.000888	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—MYC—multiple sclerosis	6.01e-07	0.000882	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	5.73e-07	0.00084	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	5.73e-07	0.00084	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GPC5—multiple sclerosis	5.24e-07	0.000768	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—RRM1—multiple sclerosis	4.34e-07	0.000637	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.07e-07	0.000597	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—BCHE—multiple sclerosis	4.05e-07	0.000593	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—MYC—multiple sclerosis	2.9e-07	0.000424	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.49e-07	0.000366	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—APOE—multiple sclerosis	2.44e-07	0.000357	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—POMC—multiple sclerosis	2.09e-07	0.000307	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALB—multiple sclerosis	1.91e-07	0.00028	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—APOE—multiple sclerosis	1.5e-07	0.00022	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—POMC—multiple sclerosis	1.29e-07	0.000189	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALB—multiple sclerosis	1.18e-07	0.000172	CbGpPWpGaD
